Envision Healthcare Co. (NYSE:EVHC) – Equities researchers at Oppenheimer cut their Q2 2018 earnings estimates for shares of Envision Healthcare in a research note issued to investors on Tuesday. Oppenheimer analyst M. Wiederhorn now anticipates that the company will post earnings per share of $0.72 for the quarter, down from their prior estimate of $0.77. Oppenheimer currently has a “Outperform” rating and a $40.00 target price on the stock. Oppenheimer also issued estimates for Envision Healthcare’s Q3 2018 earnings at $0.78 EPS, Q4 2018 earnings at $0.94 EPS and FY2018 earnings at $2.96 EPS.
Other research analysts also recently issued research reports about the stock. Stephens reaffirmed a “hold” rating and issued a $34.00 price target on shares of Envision Healthcare in a research note on Wednesday, January 10th. Robert W. Baird reduced their price target on shares of Envision Healthcare from $70.00 to $35.00 and set an “outperform” rating on the stock in a research note on Friday, November 3rd. Zacks Investment Research raised shares of Envision Healthcare from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 2nd. KeyCorp set a $40.00 price target on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Tuesday, November 14th. Finally, Jefferies Group set a $71.00 price target on shares of Envision Healthcare and gave the stock a “buy” rating in a research note on Wednesday, November 1st. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $40.73.
Envision Healthcare (NYSE:EVHC) last released its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $2.03 billion. Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. Envision Healthcare’s revenue was up 142.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.13 EPS.
A number of hedge funds have recently added to or reduced their stakes in the stock. PNC Financial Services Group Inc. boosted its stake in Envision Healthcare by 1.5% in the 2nd quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock worth $304,000 after purchasing an additional 70 shares in the last quarter. M&T Bank Corp boosted its stake in Envision Healthcare by 2.7% in the 2nd quarter. M&T Bank Corp now owns 5,420 shares of the company’s stock worth $341,000 after purchasing an additional 141 shares in the last quarter. Profund Advisors LLC boosted its stake in Envision Healthcare by 5.0% in the 2nd quarter. Profund Advisors LLC now owns 5,102 shares of the company’s stock worth $320,000 after purchasing an additional 241 shares in the last quarter. Commonwealth Bank of Australia boosted its stake in Envision Healthcare by 24.3% in the 2nd quarter. Commonwealth Bank of Australia now owns 2,096 shares of the company’s stock worth $130,000 after purchasing an additional 410 shares in the last quarter. Finally, Phocas Financial Corp. boosted its stake in Envision Healthcare by 0.4% in the 2nd quarter. Phocas Financial Corp. now owns 101,263 shares of the company’s stock worth $6,346,000 after purchasing an additional 427 shares in the last quarter.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3146027/envision-healthcare-co-expected-to-earn-q2-2018-earnings-of-0-72-per-share-evhc.html.
Envision Healthcare Company Profile
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.